- Home
- AKTX vs GROW Comparison
AKTX vs GROW Comparison
Compare AKTX & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- GROW
- Stock Information
- Founded
- AKTX N/A
- GROW 1968
- Country
- AKTX United States
- GROW United States
- Employees
- AKTX N/A
- GROW N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- AKTX Health Care
- GROW Finance
- Exchange
- AKTX Nasdaq
- GROW Nasdaq
- Market Cap
- AKTX 37.4M
- GROW 34.9M
- IPO Year
- AKTX N/A
- GROW N/A
- Fundamental
- Price
- AKTX $2.18
- GROW $2.43
- Analyst Decision
- AKTX
- GROW
- Analyst Count
- AKTX 0
- GROW 0
- Target Price
- AKTX N/A
- GROW N/A
- AVG Volume (30 Days)
- AKTX 21.4K
- GROW 40.5K
- Earning Date
- AKTX 11-19-2024
- GROW 12-12-2024
- Dividend Yield
- AKTX N/A
- GROW 3.67%
- EPS Growth
- AKTX N/A
- GROW N/A
- EPS
- AKTX N/A
- GROW 0.09
- Revenue
- AKTX N/A
- GROW $10,984,000.00
- Revenue This Year
- AKTX N/A
- GROW N/A
- Revenue Next Year
- AKTX N/A
- GROW N/A
- P/E Ratio
- AKTX N/A
- GROW $27.33
- Revenue Growth
- AKTX N/A
- GROW N/A
- 52 Week Low
- AKTX $1.08
- GROW $2.38
- 52 Week High
- AKTX $4.40
- GROW $3.11
- Technical
- Relative Strength Index (RSI)
- AKTX 23.08
- GROW 35.11
- Support Level
- AKTX $2.20
- GROW $2.38
- Resistance Level
- AKTX $2.49
- GROW $2.52
- Average True Range (ATR)
- AKTX 0.37
- GROW 0.06
- MACD
- AKTX -0.06
- GROW -0.00
- Stochastic Oscillator
- AKTX 2.56
- GROW 25.00
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.